3 terminated, 1 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 3, Completed 1 |
Follow CCX282-B: new trials by email Literature Review of CCX282-B trials Research Report on CCX282-B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease GSK1605786A - Crohn's Disease | Phase 3 | Terminated | GlaxoSmithKline | 255 | 2011-11-11 | 2018-01-29 |
| GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease GSK1605786A, Placebo - Crohn's Disease | Phase 3 | Terminated | GlaxoSmithKline | 229 | 2011-05-09 | 2017-09-07 |
| Open-Label Extension Study of GSK1605786A GSK1605786A - Crohn's Disease | Phase 3 | Terminated | GlaxoSmithKline | 399 | 2011-04-01 | 2017-09-14 |
| A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease GSK1605786A, Placebo - Crohn's Disease | Phase 3 | Completed | GlaxoSmithKline | 608 | 2010-12-20 | 2017-09-19 |
Crohn Disease (4) · Inflammatory Bowel Diseases (2)
GlaxoSmithKline (4)
Australia (4) · Austria (4) · Belgium (4) · Canada (4) · Czechia (4) · Denmark (4) · France (4) · Germany (4) · Hungary (4) · Israel (4) · Italy (4) · Japan (4) · New Zealand (4) · Poland (4) · Slovakia (4)